Study of Antithymocyte Globulin for Treatment of New-onset T1DM
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stephen Gitelman, MD
University of California, San Francisco
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital/usc School of Medicine
Los Angeles, California, United States
- Children'S Hospital and Research Center
Oakland, California, United States
- Ucsd/san Diego Children'S Hospital
San Diego, California, United States
- Diabetes Center at Ucsf
San Francisco, California, United States
- Barbara Davis Center for Childhood Diabetes, University of Colorado
Aurora, Colorado, United States
- Emory Children'S Center
Atlanta, Georgia, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Children'S Mercy Hospital
Kansas City, Missouri, United States
- University of Pennsylvania/children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2007
- Primary completion
- 30 Jun 2012
- Completion
- 31 Jul 2013
- Last update posted
- 11 May 2017
- Registered enrollment
- 58
- Registry id
- NCT00515099
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.